Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

<p>Supplementary Table S1. List of Antibodies used</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Megharani Mahajan (19810332) (author)
Outros Autores:	Alondra L. Rodriguez Sanchez (22164781) (author), Sridharan Jayamohan (22164784) (author), Dileep K. Vijayan (22164787) (author), Jessica D. Johnson (22164790) (author), Huan Xie (17316659) (author), Yang Wang (22164793) (author), Dong Liang (15107744) (author), John R. Sanchez (14958717) (author), Panneerdoss Subbarayalu (22164796) (author), Manjeet K. Rao (14956450) (author), Ratna K. Vadlamudi (12394034) (author), Gangadhara R. Sareddy (14958741) (author), Hareesh B. Nair (22164799) (author), Suryavathi Viswanadhapalli (14958693) (author)
Publicado em:	2025
Assuntos:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Cell Signaling Drug Targets Progression, Invasion & Metastasis
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados